Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Submitted by
admin
on April 16, 2011 - 12:20pm
Source:
Motley Fool
News Tags:
Amylin
Alkermes
diabetes
Eli Lilly
Bydureon
Headline:
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Do Not Allow Advertisers to Use My Personal information
